Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Beutler

Showing results (21-30 of 698) with videos related to

Pageof 70
Sort By:
Israel Journal of Medical Sciences|September 1, 1973
Screening for galactosemia. Studies of the gene frequencies for galactosemia and the Duarte variantE Beutler
Clinical Chemistry|June 1, 1997
Hair iron content: possible marker to complement monitoring therapy of iron deficiency in patients with chronic inflammatory bowel disease?E Beutler
The Western Journal of Medicine|February 1, 1994
Bone marrow transplantation beyond treatment of aplasia and neoplasiaE Beutler
Perspectives in Biology and Medicine|January 1, 1986
Planned obsolescence in humans and in other biosystemsE Beutler
The American Journal of Medicine|July 1, 1994
Economic malpractice in the treatment of Gaucher's diseaseE Beutler
Seminars in Hematology|January 1, 1994
New chemotherapeutic agent: 2-chlorodeoxyadenosineE Beutler
Life Sciences|May 15, 1975
Disorders in glutathione metabolismE Beutler
Blood Cells, Molecules & Diseases|June 6, 1998
Commentary: the natural history of Gaucher diseaseE Beutler
Blood|May 1, 1989
Glucose-6-phosphate dehydrogenase: new perspectivesE Beutler
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
About Gaucher diseaseE Beutler
Pageof 70

Showing results (21-30 of 698) with videos related to

Sort By:
Pageof 70
Israel Journal of Medical Sciences|September 1, 1973
Screening for galactosemia. Studies of the gene frequencies for galactosemia and the Duarte variantE Beutler
Clinical Chemistry|June 1, 1997
Hair iron content: possible marker to complement monitoring therapy of iron deficiency in patients with chronic inflammatory bowel disease?E Beutler
The Western Journal of Medicine|February 1, 1994
Bone marrow transplantation beyond treatment of aplasia and neoplasiaE Beutler
Perspectives in Biology and Medicine|January 1, 1986
Planned obsolescence in humans and in other biosystemsE Beutler
The American Journal of Medicine|July 1, 1994
Economic malpractice in the treatment of Gaucher's diseaseE Beutler
Seminars in Hematology|January 1, 1994
New chemotherapeutic agent: 2-chlorodeoxyadenosineE Beutler
Life Sciences|May 15, 1975
Disorders in glutathione metabolismE Beutler
Blood Cells, Molecules & Diseases|June 6, 1998
Commentary: the natural history of Gaucher diseaseE Beutler
Blood|May 1, 1989
Glucose-6-phosphate dehydrogenase: new perspectivesE Beutler
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
About Gaucher diseaseE Beutler
Pageof 70